Literature DB >> 3940202

Establishment of murine endothelial cell lines that develop angiosarcomas in vivo: brief demonstration of a proposed animal model for Kaposi's sarcoma.

N Sato, T Sato, S Takahashi, K Kikuchi.   

Abstract

We have reported previously that 100% of the incidence of malignant endotheliomas and angiosarcomas was developed in specific-pathogen-free BALB/c mice given s.c. injections of 1,2-dimethylhydrazine dihydrochloride. These tumors appeared selectively in the liver. In the present study, we have successfully established two cell lines in vitro (D10 and D14) from some of these tumors and have characterized the biological features of these lines. D10 and D14 have a 24- to 26-h doubling time and show a spindle formation in confluent monolayer cultures. The D10 line has a low capability of anchorage-independent growth in soft agar as well as less tumorigenicity in syngeneic mice. When as many as 10(7) D10 cells were injected s.c. into syngeneic mice, only one-half of the mice developed tumors composed of neoplastic endothelial cells with ample vascular lumina of various sizes. The histological appearance of this tumor resembled that of Kaposi's sarcoma as a human counterpart. The D14 line, in contrast, has a relatively high capability to grow in the soft agar culture. However, the tumor growth in vivo was less tumorigenic. None of the mice given injections of less than 10(6) D14 cells developed tumors. Although all of mice given injections of 10(7) D14 cells developed tumors, these tumors regressed completely until the 6th week after inoculation, suggesting that these cells were immunogenic in the transplantation assays using syngeneic mice. These lines may provide useful information for the study of cytological features of vascular tumors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3940202

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  Current methods for assaying angiogenesis in vitro and in vivo.

Authors:  Carolyn A Staton; Stephen M Stribbling; Simon Tazzyman; Russell Hughes; Nicola J Brown; Claire E Lewis
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

2.  Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells.

Authors:  L Schweigerer; G Neufeld; D Gospodarowicz
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

Review 3.  A critical analysis of current in vitro and in vivo angiogenesis assays.

Authors:  Carolyn A Staton; Malcolm W R Reed; Nicola J Brown
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

4.  Development of multiple necrotizing enteritis induced by a tumor necrosis factor-like cytokine from lipopolysaccharide-stimulated peritoneal macrophages in rats.

Authors:  K Torimoto; N Sato; M Okubo; A Yagihashi; Y Wada; I Hara; H Hayasaka; K Kikuchi
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

Review 5.  Modeling human endothelial cell transformation in vascular neoplasias.

Authors:  Victoria W Wen; Karen L MacKenzie
Journal:  Dis Model Mech       Date:  2013-09       Impact factor: 5.758

6.  Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin.

Authors:  T Shishido; T Yasoshima; R Denno; M Mukaiya; N Sato; K Hirata
Journal:  Jpn J Cancer Res       Date:  1998-09

7.  Antitumor effect of recombinant human interleukin-2 on the growth of murine hemangioendothelioma D14 in nude mice: occurrence of large granular cells in the tumor.

Authors:  Y Sakura; T Houkan; K Ootsu; A Shino
Journal:  Jpn J Cancer Res       Date:  1991-08

8.  The expression of tumor rejection antigen on rat fetus fibroblasts transformed by the ras oncogene.

Authors:  M Okubo; A Yagihashi; T Torigoe; A Konno; N Sato; K Kikuchi
Journal:  Jpn J Cancer Res       Date:  1988-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.